Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 603 across all filing types
Latest filing 2023-05-10 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase transactions with dates, quantities, and prices, as well as confirmations related to compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on share repurchases and capital changes rather than financial results, management changes, or legal matters. The document is lengthy (15,000 characters) and contains substantive data on share repurchases. This matches the definition of a 'Transaction in Own Shares' filing, which reports on the company's buyback activities. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2023-05-10 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates, quantities, and prices, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in capital structure rather than financial results, management changes, or regulatory certifications. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not merely an announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2023-05-09 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares with dates, quantities, and prices, as well as confirmations regarding compliance with listing rules. The document references the Main Board Listing Rules and GEM Listing Rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase activities and changes in issued share capital, which aligns with announcements regarding share buybacks or capital changes. It is not a full financial report, earnings release, or management discussion. The detailed nature and regulatory references indicate it is a formal announcement of share repurchase activity rather than a general regulatory filing or a report publication announcement. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS). The document length (15,000 characters) supports it being a substantive disclosure rather than a brief announcement.
2023-05-08 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares with dates, quantities, and prices, as well as confirmations related to compliance with listing rules. The content focuses on reporting share repurchases and changes in issued shares, which aligns with disclosures about transactions in the company's own shares. There is no indication that this is a full financial report, earnings release, or management discussion. The document is not a brief announcement but a detailed disclosure of share repurchase activity. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS).
2023-05-05 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed data on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and changes in issued shares, which aligns with reporting on transactions involving the company's own shares. There is no indication that this is a full financial report, earnings release, or management discussion. The document is not a simple announcement of a report but a detailed disclosure of share repurchase transactions. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2023-05-04 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is a detailed disclosure of changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes specific dates and quantities of shares repurchased, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The document is a regulatory disclosure form (FF304) related to share repurchases and capital changes, not a financial report or earnings release. It is not a report publication announcement since it contains substantive data on share repurchases. The content fits the category of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares.
2023-05-03 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.